메뉴 건너뛰기




Volumn 108, Issue 3, 2006, Pages 1108-1109

Anti-EpoR antibodies detect a 59-kDa EpoR protein [4]

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CELL EXTRACT; CELL SURFACE RECEPTOR; ERYTHROPOIETIN ANTIBODY; ERYTHROPOIETIN RECEPTOR; GAP JUNCTION PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; SHORT HAIRPIN RNA;

EID: 33746642493     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (9)

References (8)
  • 1
    • 33344461329 scopus 로고    scopus 로고
    • Anti-Epo receptor antibodies do not predict Epo receptor expression
    • Elliott S, Busse L, Bass MB, et al. Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood. 2006;107:1892-1895.
    • (2006) Blood , vol.107 , pp. 1892-1895
    • Elliott, S.1    Busse, L.2    Bass, M.B.3
  • 2
    • 0000857494 scopus 로고
    • An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database
    • Eng JK, McCormick AL, Yates JR III. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. JASMS. 1994;5:976-989.
    • (1994) JASMS , vol.5 , pp. 976-989
    • Eng, J.K.1    McCormick, A.L.2    Yates III, J.R.3
  • 3
    • 24944454286 scopus 로고    scopus 로고
    • Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
    • Leyland-Jones B, Semiglazov V, Pawlicki M, et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol. 2005;23:5960-5972.
    • (2005) J Clin Oncol , vol.23 , pp. 5960-5972
    • Leyland-Jones, B.1    Semiglazov, V.2    Pawlicki, M.3
  • 4
    • 0142186283 scopus 로고    scopus 로고
    • Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial
    • Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003;362:1255-1260.
    • (2003) Lancet , vol.362 , pp. 1255-1260
    • Henke, M.1    Laszig, R.2    Rube, C.3
  • 5
    • 1442332088 scopus 로고    scopus 로고
    • Erythropoietin to treat anaemia in patients with head and neck cancer
    • author reply 81-82
    • Haddad R, Posner M. Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet. 2004;363:79-80; author reply 81-82.
    • (2004) Lancet , vol.363 , pp. 79-80
    • Haddad, R.1    Posner, M.2
  • 6
    • 0041976976 scopus 로고    scopus 로고
    • Breast cancer trial with erythropoietin terminated unexpectedly
    • Leyland-Jones B. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol. 2003;4:459-460.
    • (2003) Lancet Oncol , vol.4 , pp. 459-460
    • Leyland-Jones, B.1
  • 7
    • 1442307804 scopus 로고    scopus 로고
    • Erythropoietin to treat anaemia in patients with head and neck cancer
    • author reply 81-82
    • Leyland-Jones B, Mahmud S. Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet. 2004;363:80; author reply 81-82.
    • (2004) Lancet , vol.363 , pp. 80
    • Leyland-Jones, B.1    Mahmud, S.2
  • 8
    • 1442332088 scopus 로고    scopus 로고
    • Erythropoietin to treat anaemia in patients with head and neck cancer
    • author reply 81-82
    • Kaanders JH, van der Kogel AJ. Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet. 2004;363:78-79; author reply 81-82.
    • (2004) Lancet , vol.363 , pp. 78-79
    • Kaanders, J.H.1    Van Der Kogel, A.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.